PADI4 and obesity disorder: In the HFD-induced obesity model in male mice, deletion of PAD4 in hematopoietic cells (Padi4KO) or pharmacologic inhibition of PADI4 by the selective PADI4 inhibitor GSK484 did not affect body weight gain or fat accumulation (39).